《Veterinary college study and pioneering database tackle most common heart disease in dogs》

  • 来源专题:科学技术史学科动态
  • 编译者: ihns
  • 发布时间:2016-03-09
  • When Jane Shaw of Floyd, Virginia, brought her 14-year-old border collie, Clio, into the Veterinary Teaching Hospital last fall, she learned about a clinical research study at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech that might help other dogs with similar heart conditions.

    Veterinary researchers hope to determine whether an echocardiogram — a noninvasive type of ultrasound that uses sound waves to measure heart function — can effectively assess the pulmonary pressure on dogs with mitral valve disease. Mitral valve disease is the most common form of cardiac disease in the species, and pulmonary hypertension, which involves abnormally high pressures in the pulmonary vessels, is a typical complication affecting 25 to 30 percent of dogs with the disease.

    “Participating in the study seems like a no-brainer,” said Shaw, whose sister’s pet had participated in an earlier clinical trial at the college. “When I learned that Virginia Tech was doing a study on the same problem that Clio had, I knew we should sign up. This study helps us and it helps other patients with the same disease.”

    Mitral valve disease occurs when the heart’s left valve does not close properly, leading to a backflow of blood. According to Michele Borgarelli, associate professor of cardiology in the Department of Small Animal Clinical Sciences, it affects nearly all dogs over 10 years old, though many will never develop symptoms.

    “There are certain breeds that are more susceptible to mitral valve disease, especially small breed dogs,” said Borgarelli, who is the principle investigator on the study. “Among these dogs, Cavalier King Charles, dachshunds, miniature poodles, and whippets are more commonly affected.”

    Like other diseases, symptoms can range from mild to severe. The study, which began in 2013, compares the results of an echocardiogram to the “gold standard” method of assessing pulmonary hypertension used in human medicine, where a catheter placed in the right side of the heart measures pulmonary vessel pressure.

    Borgarelli performs an echocardiogram on each dog enrolled in the study, while his research partner Jonathan Abbott, associate professor of cardiology in the Department of Small Animal Clinical Sciences, takes the same measurement using the catheter. The researchers will not compare the results of each procedure until the study’s completion so that they do not inadvertently affect the outcome.

    According to Abbott, the catheter procedure is the tried and true way to measure pulmonary hypertension, but it is rarely performed in veterinary practices. If the study finds that an echocardiogram can produce accurate results, veterinarians would know that they have a reliable, noninvasive way to measure this common complication in patients with mitral valve disease.

    In a related project, Borgarelli is also spearheading a first-of-its-kind database to serve as a reference library about dogs with mitral valve disease.

    “Despite being the most common cardiovascular disease in dogs, we don’t have much data to better understand the natural history of mitral valve disease or assess what happens to the dogs once a veterinarian makes a diagnosis,” he explained. “Through this database, we are collecting a large amount of data from as many patients as possible and then following them for the next five years.”

    The database will allow researchers to pose questions about which metrics predict outcomes and which interventions affect prognosis. No such database currently exists for mitral valve disease, but according to Borgarelli, disease registries have proven effective in other veterinary and human diseases. He added, “The preliminary phase of the study started in October, and we are already tracking data on more than 500 dogs in just a few months.”

    While patients with a new diagnosis at the Veterinary Teaching Hospital in Blacksburg are entered into the database, the investigators are also broadening their reach through the college’s Collaborative Research Network, which was formed in 2014 to enable specialty practices in Virginia and Maryland to participate in the veterinary college’s cutting-edge research. They are partnering with Bill Tyrrell, a 1992 graduate of the veterinary college, and other clinicians at Chesapeake Veterinary Cardiology Associates, a group of cardiac specialty practices in northern Virginia and Maryland, as well as the Swedish University of Agricultural Sciences in Uppsala, Sweden, to expand the database.

    The college’s cardiac research has also benefited from support from Ceva Santé Animale, a global veterinary health company.

    The college maintains a complete list of current trials involving dogs, cats, and horses on its Veterinary Clinical Research Office website.

    The Virginia-Maryland College of Veterinary Medicine is a leading biomedical teaching and research center, enrolling more than 700 Doctor of Veterinary Medicine, master of public health, and biomedical and veterinary sciences graduate students. The college is a partnership between the land-grant universities of Virginia Tech and the University of Maryland. Its main campus in Blacksburg, Virginia, features the Veterinary Teaching Hospital and large animal field services which together treat more than 79,000 animals annually. Other locations include the Marion duPont Scott Equine Medical Center in Leesburg, Virginia, and the Gudelsky Veterinary Center in College Park, Maryland.

    Follow Virginia Tech

    ? ? ? ? ?

    Top News

    Article Image

    Volunteers needed for student tree planting event along Stroubles Creek

    Article Image

    Virginia Tech awarded federal grant to benefit entrepreneurial efforts in region

    Article Image

    Science alumnus James Lough helps with historic discovery of gravitational waves

    Contact:

    Michael Sutphin

    540-231-6716

相关报告
  • 《JAMA,3月25日,An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-26
    • An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases Chengzhi Yang, MD, PhD1; Zening Jin, MD, PhD1 JAMA Cardiol. Published online March 25, 2020. doi:10.1001/jamacardio.2020.0934 The outbreak of novel coronavirus disease 2019 (COVID-19), which emerged in Wuhan, China, in December 2019, has rapidly spread to more than 58 countries and areas.1 As of March 1, 2020, about 79?968 cases in mainland China have been confirmed and 2873 deaths have occurred.1 The Chinese government is mustering medical personnel around the country to treat patients in Hubei province and preventing further spread of COVID-19 in every region of the country. At the same time, several studies concerning the epidemiological and clinical features of COVID-19 have been published in a timely manner, which has greatly helped health care workers and policy makers to understand COVID-19. Reading these reports, we noticed that many patients with COVID-19 had comorbid chronic cardiovascular diseases (CVDs), which collectively represent the most common noncommunicable epidemic in China currently. Among 44?672 individuals confirmed to have COVID-19 as of February 11, 2020, 2683 patients (12.8%) had hypertension and 873 (4.2%) had CVDs,2 which were the most common coexisting conditions in patients hospitalized with COVID-19.3,4 Furthermore, patients with comorbid CVDs were more likely to have severe illness associated with COVID-19 and had a much higher fatality rate: 10.5% for those with CVDs and 6.0% for hypertension, while the fatality rate was 0.9% in patients who reported no comorbid conditions.2 This information indicated that individuals with underlying chronic CVDs were both more susceptible to COVID-19 and more prone to critical conditions and death. It is well known that acute pulmonary infection can potentially destabilize cardiac diseases, such as heart failure and coronary artery disease. Then deterioration of cardiac diseases would exacerbate COVID-19 management in turn.
  • 《MedRixv,2月23日,The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-24
    • The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province Jinwei Ai, Junwen Chen, Yong Wang, Xiaoyun Liu, Wufeng Fan, Gaojing Qu, Meiling Zhang, Shengduo Polo Pei, Bowen Tang, Shuai Yuan, Yang Li, Lisha Wang, Guoxin Huang, Bin Pei doi: https://doi.org/10.1101/2020.02.19.20025023 Abstract Summary Objective To describe the epidemiological and clinical characteristics of the Coronavirus Disease 2019 (COVID-19) hospitalized patients and to offer suggestions to the urgent needs of COVID-19 prevention, diagnosis and treatment. Methods We included 102 confirmed COVID-19 cases hospitalized in Xiangyang No.1 peoples hospital, Hubei, China until Feb 9th, 2020. Demographic data, laboratory findings and chest computed tomographic (CT) images were obtained and analyzed. Findings All cases were confirmed by real-time RT-PCR, including 52 males and 50 females with a mean age of 50.38 years (SD 16.86). Incubation time ranged from one to twenty days with a mean period of 8.09 days (SD 4.99). Fever (86[84.3%] of 102 patients), cough (58[57%]), fatigue (28[27%]), shortness of breath (24[23%]), diarrhea (15[15%]), expectoration (13[12%]), inappetence (11[10%]) were common clinical manifestations. We observed a decreased blood leukocyte count and lymphopenia in 21 (20.6%) and 56 (54.9%) patients, respectively. There were 66 (68%) of 97 patients with elevated C-reactive protein levels and 49 (57.6%) of 85 with increased erythrocytes sedimentation rate. Higher levels of procalcitonin and ferritin were observed in 19 (25.3%) of 75 and 12 (92.3%) of 13 patients, respectively. Eight patients were admitted to intensive care unit (ICU), six developed respiratory failure, three had multiple organ failure and three died. The cumulative positivity rate over three rounds of real-time RT-PCR was 96%. One-hundred patients were found with typical radiological abnormalities in two rounds of chest CT scans, indicating a 98% consistency with real-time RT-PCR results. Interpretation Most COVID-19 patients in Xiangyang were secondary cases without sex difference, and the rate of severe cases and death was low. Middle-to-old-age individuals were more susceptible to the virus infection and the subsequent development of severe/fatal consequences. The average incubation period was longer among our patients. We recommend prolonging the quarantine period to three weeks. Three times real-time RT-PCR plus two times CT scans is a practical clinical diagnosis strategy at present and should be used to increase the accuracy of diagnosis, thereby controlling the source of infection more effectively. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.